Page 143 - CW E-Magazine (26-3-2024)
P. 143

Top Stories                                                                     Pharmaceuticals


 BIOFUELS  CURBING INDUCEMENTS
 Ethanol as fuel launched by Petroleum Minister  Government issues marketing code for pharmaceutical

       fi rms
 Mr. Hardeep Singh Puri, Union
 Minister for Petroleum & Natural Gas
 (MoPNG)  and Housing and Urban   The Department of Pharmaceuticals  ceutical  company or its agent, i.e.,  sistent with the terms of its market-
 Affairs, launched ‘Ethanol 100’, an eth-  issued the Uniform Code for Pharma-  distributors, wholesalers, retailers, etc.  ing approval, and a drug must not be
 anol-based automotive fuel at an Indi-  ceutical Marketing Practices (UCP-  Additionally, no pecuniary  advantage  promoted prior to the receipt of its
 an Oil Corporation (IOC) retail outlet   MP) 2024 on March 13, specifying the  or benefi t in kind may be offered, sup-  marketing approval from the compe-
 in New Delhi on March 15, 2024. This   rules of the use of the words “safe’’ and  plied or promised to any person quali-  tent authority, authorising its sale or
 marks the launch of  the fuel at  select   “new’’ for drugs, and stated that medi-  fi ed to prescribe or supply drugs by any  distribution.
 183  retail  outlets  across  fi ve  states  –   cal  representatives must  not  employ  pharmaceutical company or its agent.
 Maharashtra, Karnataka, Uttar Pradesh,   any  inducement  or subterfuge  to  gain   “Claims for the usefulness of a drug
 New Delhi, and Tamil Nadu.  an interview, and that they must not   The  latest UCPMP also  notes that  must be based on up-to-date evaluation
       pay, under any guise, for access to a  paid travel, hotel stays, etc., should not  of  all available evidence.  The word
 Mr. Pankaj Jain, Secretary, MoPNG;   healthcare professional.  be extended to healthcare professionals  ‘safe’ must not be used without quali-
 Mr. S.M. Vaidya, Chairman, IOC, senior   or their family members by pharma-  fi cation, and it must not be stated cate-
 offi cials from MoP&NG, and functional   Engagement of the pharmaceutical  ceutical companies or their representa-  gorically  that a medicine  has no side
 Directors of IOC also participated  in   industry with healthcare professio-  tives, unless the person is a speaker for  effects, toxic hazards, or risk of addic-
 the launch ceremony.  nals for Continuing Medical Education  a CME, etc.  tion. The word ‘new’ must not be used
       (CME) should only be allowed through                               to describe any drug which has been
 ‘Ethanol 100’ is not 100% ethanol.   a well-defi ned, transparent, and verifi -  The UCPMP is to be circulated for  generally  available or any therapeutic
 It includes 93-93.5% ethanol  blended   able set of guidelines, and conduct of  strict compliance, and all industry asso-  intervention which has been generally
 with 5% petrol and 1.5% co-solvent.   such events in foreign locations is pro-  ciations have been requested to consti-  promoted in India for more than a
 exchange, and boosting the agricul-  ethanol blending by 2025-26. During   hibited by the uniform code.  tute an Ethics Committee for Pharma-  year,” the latest rules state.
 Calling it a revolutionary fuel, the  ture sector. Since the Prime Minister’s  the last 10 years these ethanol blend-  ceutical  Marketing Practices, set up a
 Minister said that ‘Ethanol 100’ fuel has  announcement on E20 (20% ethanol  ing initiatives have enhanced farmer   Companies or their representatives  dedicated UCPMP portal on their web-  All Indian pharmaceutical associ-
 the potential to transform our transpor-  blended fuel) in 2023, the E20 availabi-  incomes, increased rural employment,   should not pay cash or monetary grants  site, and take further necessary steps for  ations are to upload the UCPMP on
 tation sector and reduce our dependence  lity has increased to 12,000 outlets in  reduced CO  emissions equivalent to   to any healthcare professional or their  the code’s implementation.  their website along with the detailed
 2
 on fossil fuels. “It refl ects the govern-  under a year, and now, with the launch of  planting 1.75-crore trees and resulted   family members  (both  immediate and   procedure for lodging of complaints,
 ment’s commitment to reducing im-  ‘Ethanol100’ at 183 outlets of IOC, we  in savings of Rs. 85,000-crore worth of   extended) under any pretext.  Promotion of drugs  which will be linked to the UCPMP
 port dependency, conserving foreign  are close to achieving the target of 20%  foreign exchange,” the Minister stated.  On drugs, the UCPMP states that  portal of the Department of Pharma-
          Gifting is prohibited by any pharma-  promotion of a drug must be con-  ceuticals.
 ICT Drinking water technology bags grant   DOMESTIC OFFERING

 from Cummins  Zydus Lifesciences launches cancer drug, Olaparib


 A start-up from the Institute of   can  be  retrofi tted  in  existing  hand-  Zydus Lifesciences has launched  be administered this PARP inhibitor  diagnosed with these specifi c cancers, the
 Chemical Technology (ICT), Mumbai,   pumps and it doesn’t require chemicals   cancer drug Olaparib, a PARP inhibitor,  which can delay the progression of the  right diagnosis and the right treatment
 HydroCawach Technologies Pvt. Ltd.,   or electricity to operate.  under the brand name IBYRA in India.  disease.  early on can give them a big advantage
 has signed an agreement with  Venture                                    in the fi ght against cancers. Our patient
 Center, CSIR-National Chemical Labo-  This innovation behind the device   The  drug  targets  specifi c  genetic   To help identify the right patients and  support focus in launching IBYRA helps
 ratory (CSIR-NCL), Pune, for the   stems from the research work of   mutations prevalent in certain types  facilitate access, Zydus has collaborated  them with both cutting-edge diagnosis
 Cummins Corporate Social Responsi-  Dr. Aniruddha Pandit, Vice Chancellor,   of cancers, paving the  way for more  with MedGenome for comprehensive  for HRD positive cancer and precision
 bilty (CSR) grant.   ICT, Mumbai, and Dr. Nilesh L Jadhav,   tailored and effective treatment approach.  HRD testing. The price for this, along  therapy in the most affordable way.
 Founder Director, HydroCawach Tech-     with a year-long treatment of IBYRA,  We believe this will reduce the disease
 The aim of the project is to deploy   nology, and promises to provide clean   Among cancer patients in India,  has been capped at Rs. 3-lakh, as com-  burden for the patients in a signifi cant
 and validate a novel water disinfecting,  Mark  II  Handpumps’,  benefi ting rural  and safe drinking water for people in   those who are diagnosed as HRD posi-  pared to the cost of around Rs. 72-lakh  way,” said Dr. Sharvil Patel, Managing
 no-maintenance  attachment  for  ‘India  communities  across India. The device  rural India.  tive or with BRACA mutation need to  by the innovator. “For patients newly  Director, Zydus Lifesciences.


 142  Chemical Weekly  March 26, 2024  Chemical Weekly  March 26, 2024                                 143


                                      Contents    Index to Advertisers    Index to Products Advertised
   138   139   140   141   142   143   144   145   146   147   148